Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Clinical trial NCT05488678 · COMPLETED
Trial details
- NCT number
- NCT05488678
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-11-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.